Treatment Plan for Epistaxis (R04.0)
Begin immediate treatment with firm external nasal pressure for 10-15 minutes while the patient sits upright and leans forward, followed by topical vasoconstrictor application (oxymetazoline) if bleeding persists, then proceed to cautery or nasal packing based on bleeding site identification. 1
Initial Assessment and Risk Stratification
Document critical risk factors immediately: 1
- Personal or family history of bleeding disorders 1
- Anticoagulant or antiplatelet medication use (aspirin, clopidogrel, warfarin) 1, 2
- Intranasal drug use 1
- Prior nasal/sinus surgery or facial trauma 1
- Chronic kidney or liver disease 1
- CPAP or nasal cannula oxygen use 1
Identify bleeding location: 1
- Anterior epistaxis (95% of cases) - typically Kiesselbach's plexus 3
- Posterior epistaxis (5% of cases) - requires more aggressive intervention 3
- Consider nasal endoscopy for recurrent, severe, or difficult-to-control bleeding (localizes bleeding site in 87-93% of cases) 1
Stepwise Treatment Algorithm
Step 1: First-Line Interventions (Controls 65-75% of Cases)
- Pinch soft area of nose firmly for 10-15 minutes 1
- Patient sits upright, leans forward to prevent blood swallowing 4
Topical vasoconstrictors (if pressure fails): 1
- Oxymetazoline 0.05% spray or on cotton pledget 1, 4
- Alternative: phenylephrine 1
- Stops bleeding in 65-75% of emergency department cases 1, 5
- Caution: May increase cardiac complications in susceptible patients 1
Step 2: Definitive Treatment for Identified Bleeding Site
For anterior bleeding with visible source: 1
Cauterization (preferred for localized bleeding): 1, 5
- Chemical cautery: Silver nitrate application after topical anesthesia 1, 4
- Electrocautery: More effective than chemical with fewer recurrences (14.5% vs 35.1%) 5
- Apply to decongested and anesthetized mucosa 4
- Avoid bilateral septal cautery to prevent perforation 1
Topical tranexamic acid (especially for antiplatelet users): 2
- Mean bleeding cessation time: 6.7 minutes vs 11.5 minutes with phenylephrine-lidocaine packing 2
- Reduces rebleeding: 6% vs 20% with traditional packing 2
- Particularly effective in patients on aspirin or clopidogrel 2
- Promotes hemostasis in 78% of patients vs 35% with oxymetazoline 5
Step 3: Nasal Packing (If Above Measures Fail)
Anterior packing options: 5, 4
- Inflatable anterior nasal balloon packs (Rapid-Rhino) - reliably control most nosebleeds 4
- PVA nasal tampons (Merocel) 5
- Absorbable materials: Nasopore nasal tampon 5
- Newer hemostatic materials (more effective, fewer complications): 5
Posterior packing (for posterior epistaxis): 4
Packing management: 1
- Consider prophylactic antibiotics if infection risk is high 1
- Keep packing moist with nasal saline sprays 1
- Strict follow-up for nonresorbable packing removal 1
- Monitor for complications: infection, septal perforation, pressure necrosis 1
Step 4: Advanced Interventions (Refractory Cases)
Endoscopic surgical management: 5, 6
- Endoscopic sphenopalatine artery (SPA) ligation: 97% success vs 62% with packing alone 5, 6
- Endoscopic cauterization: More effective than ligation 5
- Consider early surgery over prolonged packing for posterior epistaxis 6
Interventional radiology: 5, 7
- Percutaneous embolization using gelatin sponge, foam, PVA, or coils 5
- 80% success rate 5
- Alternative for high-risk surgical candidates 7
- Typically reserved after surgical failure, except in specific high-risk patients 6
Post-Treatment Management
Activity restrictions: 1
- Avoid straining, lifting >10 pounds, bending over, exercising 1
- Sleep with head elevated 1
- No nose blowing with packing in place 1
- Sneeze with mouth open 1
Pain management: 1
- Acetaminophen (Tylenol) - does not increase bleeding 1
- Avoid aspirin and ibuprofen - increase bleeding risk 1
Nasal care: 1
- Nasal saline spray throughout day 1
- Moisturizing/lubricating agents after bleeding stops 1
- Humidifier use 1
Discharge instructions with oxymetazoline 0.05% spray for rebleeding management 4
Warning Signs Requiring Immediate Re-evaluation
Instruct patients to return for: 1
- Return of blood from nose or mouth 1
- Fever >101°F 1
- Increasing pain 1
- Vision changes 1
- Shortness of breath or labored breathing 1
- Loss of color around nasal skin 1
- Facial swelling 1
- Diffuse skin rash 1
Special Considerations
For patients on anticoagulation/antiplatelet therapy: 2
- Topical tranexamic acid is particularly effective 2
- Do not routinely discontinue anticoagulation without consulting prescribing physician 1
Recurrent epistaxis: 1